Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.99%) $83.02
Gas
(-1.16%) $1.619
Gold
(-0.47%) $2 336.20
Silver
(-0.84%) $27.31
Platinum
(0.41%) $925.90
USD/EUR
(-0.12%) $0.934
USD/NOK
(-0.06%) $11.02
USD/GBP
(-0.18%) $0.799
USD/RUB
(0.00%) $92.17

Echtzeitaktualisierungen für Eris Lifesciences Limited [ERIS.NS]

Börse: NSE Sektor: Healthcare Industrie: Drug Manufacturers—Specialty & Generic
Zuletzt aktualisiert26 Apr 2024 @ 11:59
25% discount on Stockinvest.us - Use code: Podcast

1.06% INR 892.95

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:59):

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology...

Stats
Tagesvolumen 58 756.00
Durchschnittsvolumen 230 030
Marktkapitalisierung 121.48B
EPS INR0 ( 2024-02-13 )
Nächstes Ertragsdatum ( INR0 ) 2024-05-14
Last Dividend INR7.35 ( 2022-08-11 )
Next Dividend INR0 ( N/A )
P/E 31.44
ATR14 INR0.844 (0.09%)

Volumen Korrelation

Lang: -0.11 (neutral)
Kurz: 0.12 (neutral)
Signal:(49.564) Neutral

Eris Lifesciences Limited Korrelation

10 Am meisten positiv korreliert
NECCLTD.NS0.892
BINDALAGRO.NS0.889
ROSSARI.NS0.887
SETFNIF50.NS0.882
AXISNIFTY.NS0.881
INDIANHUME.NS0.881
KOTAKNIFTY.NS0.88
ICICINIFTY.NS0.879
LICNFNHGP.NS0.879
BSLNIFTY.NS0.878
10 Am meisten negativ korreliert
SOMATEX.NS-0.88
JSL.NS-0.873
4THDIM.NS-0.859
KARDA.NS-0.839
BSELINFRA.NS-0.83
ISMTLTD.NS-0.819
GAIL.NS-0.817
KIRLFER.NS-0.815
FOSECOIND.NS-0.809
TARMAT.NS-0.804

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Eris Lifesciences Limited Korrelation - Währung/Rohstoff

The country flag 0.00
( neutral )
The country flag -0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.10
( neutral )
The country flag -0.07
( neutral )
The country flag 0.15
( neutral )

Eris Lifesciences Limited Finanzdaten

Annual 2022
Umsatz: INR16.62B
Bruttogewinn: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Umsatz: INR16.62B
Bruttogewinn: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Umsatz: INR13.26B
Bruttogewinn: INR10.65B (80.33 %)
EPS: INR29.89
FY 2021
Umsatz: INR11.93B
Bruttogewinn: INR9.51B (79.72 %)
EPS: INR26.16

Financial Reports:

No articles found.

Eris Lifesciences Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR7.35
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Eris Lifesciences Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.44 - low (14.40%) | Divividend Growth Potential Score: 5.04 - Potential for dividend initiation, but uncertain (0.70%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.87 2020-03-19
Last Dividend INR7.35 2022-08-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR21.73 --
Avg. Dividend % Per Year 0.44% --
Score 1.99 --
Div. Sustainability Score 3.44
Div.Growth Potential Score 5.04
Div. Directional Score 4.24 --
Next Divdend (Est)
 (2024-10-30)
INR0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
1.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2020 INR8.37 1.69%
2021 INR6.01 1.02%
2022 INR7.35 0.96%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
UBL.NS Dividend Junior 2023-08-03 Annually 17 0.27%
POLYCAB.NS Dividend Knight 2023-06-21 Annually 6 0.50%
JSL.NS Dividend Junior 2023-09-15 Sporadic 22 0.26%
DLF.NS Dividend Junior 2023-07-28 Annually 18 0.60%
AARON.NS Dividend Junior 2023-08-28 Sporadic 5 0.36%
SOUTHBANK.NS Dividend Junior 2023-08-17 Sporadic 25 0.42%
MONARCH.NS Dividend Junior 2023-09-14 Annually 3 0.20%
HERANBA.NS Dividend Junior 2023-08-17 Annually 4 0.20%
BHEL.NS Dividend Junior 2023-08-11 Annually 21 0.26%
RAMCOIND.NS Dividend Junior 2023-08-02 Annually 23 0.32%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2101.5005.808.70[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1671.5009.2610.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM8.081.0008.128.12[3 - 30]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
freeCashFlowPerShareTTM19.152.000.4240.847[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.8181.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2661.0006.676.67[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.44

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM31.431.0006.930[1 - 100]
returnOnEquityTTM0.1672.509.5210.00[0.1 - 1.5]
freeCashFlowPerShareTTM19.152.003.620.847[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.201.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1421.0008.960[0.1 - 0.5]
Total Score5.04

Eris Lifesciences Limited

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.